Hardy Reed LLC Abb Vie Inc. Transaction History
Hardy Reed LLC
- $1.22 Billion
- Q2 2025
A detailed history of Hardy Reed LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hardy Reed LLC holds 9,846 shares of ABBV stock, worth $1.96 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,846
Previous 11,648
15.47%
Holding current value
$1.96 Million
Previous $2.44 Million
25.12%
% of portfolio
0.15%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,274Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$8.28 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...